Tiotropium / Respimat One-Year Study

NCT00168831 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1007

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium Inhalation Solution
OTHER: Placebo

Sponsor

Boehringer Ingelheim